Abad, Arlene .
HRN: 15-08-88 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2023
CEFUROXIME 500MG (TAB)
05/07/2023
05/14/2023
PO
500mg
BID For 7 Days
S/P Nsvd, Infection
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes